Literature DB >> 34116816

Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health.

Alexis S Hammond1, Mary M Sweeney2, Tanyaradzwa U Chikosi2, Maxine L Stitzer3.   

Abstract

Digital health tools can provide convenient delivery of evidence-based treatments. The DynamiCare Health smartphone app delivers a contingency management intervention for substance use disorder consisting of remote self-testing for alcohol (breath) and drugs (saliva) with remote test validation and delivery of financial incentives for negative test results. This study examined feasibility, engagement (duration and consistency of app utilization), and impact on usual care treatment participation when a community substance use treatment program implemented this digital therapy among its patients. The study randomly assigned patients with alcohol use disorder (N = 61) to receive either DynamiCare along with treatment-as-usual (TAU; N = 29) or TAU only (N = 32) during a 90-day evaluation period. Mean duration between first and last app use was 64 (±35) days, with mean earnings of $248 (±$209, out of $600 maximum). Among those with any app use (n = 25), compliance was 68% and 74%, respectively for requested breath and saliva samples. Overall, two thirds of patients (66%) assigned to the app used it for at least 57 days and with high rates of self-testing compliance. Those completing the assessment (n = 13; 45% of sample) endorsed high satisfaction ratings. DynamiCare versus TAU participants were more likely to be retained in usual care treatment at 90 days (24% vs 3%; (χ2 (1, 61) = 5.9, p < 0.05), but sustained app utilization was associated with a wide range of usual care treatment participation. These data suggest that DynamiCare Health is feasible and potentially beneficial as a complement to community substance use treatment programs.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol use disorder; Digital health; DynamiCare Health; Feasibility; Mobile app; Technology

Mesh:

Year:  2021        PMID: 34116816      PMCID: PMC8197772          DOI: 10.1016/j.jsat.2021.108425

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  19 in total

Review 1.  Contingency management for treatment of substance use disorders: a meta-analysis.

Authors:  Michael Prendergast; Deborah Podus; John Finney; Lisa Greenwell; John Roll
Journal:  Addiction       Date:  2006-11       Impact factor: 6.526

2.  Empirically supported substance abuse treatment approaches: a survey of treatment providers' perspectives and practices.

Authors:  Diane M Herbeck; Yih-Ing Hser; Cheryl Teruya
Journal:  Addict Behav       Date:  2007-12-23       Impact factor: 3.913

3.  Prize-based contingency management for the treatment of substance abusers: a meta-analysis.

Authors:  Lois A Benishek; Karen L Dugosh; Kim C Kirby; Jason Matejkowski; Nicolle T Clements; Brittany L Seymour; David S Festinger
Journal:  Addiction       Date:  2014-05-23       Impact factor: 6.526

4.  App Aids Treatment Retention for Opioid Use Disorder.

Authors:  Rebecca Voelker
Journal:  JAMA       Date:  2019-02-05       Impact factor: 56.272

5.  Nationwide access to an internet-based contingency management intervention to promote smoking cessation: a randomized controlled trial.

Authors:  Jesse Dallery; Bethany R Raiff; Sunny Jung Kim; Lisa A Marsch; Maxine Stitzer; Michael J Grabinski
Journal:  Addiction       Date:  2017-01-25       Impact factor: 6.526

6.  Contingency management in outpatient methadone treatment: a meta-analysis.

Authors:  J D Griffith; G A Rowan-Szal; R R Roark; D D Simpson
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

7.  A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.

Authors:  Kenneth Silverman; Elias Robles; Timothy Mudric; George E Bigelow; Maxine L Stitzer
Journal:  J Consult Clin Psychol       Date:  2004-10

Review 8.  Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice.

Authors:  Kathleen M Carroll
Journal:  Ann N Y Acad Sci       Date:  2014-09-09       Impact factor: 5.691

9.  The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients.

Authors:  Sandra Lapham; Robert Forman; Mark Alexander; Ari Illeperuma; Michael J Bohn
Journal:  J Subst Abuse Treat       Date:  2008-09-04

10.  Remote Alcohol Monitoring to Facilitate Incentive-Based Treatment for Alcohol Use Disorder: A Randomized Trial.

Authors:  Mikhail N Koffarnus; Warren K Bickel; Anita S Kablinger
Journal:  Alcohol Clin Exp Res       Date:  2018-10-18       Impact factor: 3.455

View more
  5 in total

1.  A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth.

Authors:  Amanda M Palmer; Rachel L Tomko; Lindsay M Squeglia; Kevin M Gray; Matthew J Carpenter; Tracy T Smith; Jennifer Dahne; Benjamin A Toll; Erin A McClure
Journal:  Drug Alcohol Depend       Date:  2022-01-19       Impact factor: 4.492

2.  Rewarding recovery: the time is now for contingency management for opioid use disorder.

Authors:  Steven L Proctor
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

3.  A randomized controlled trial of contingency management for smoking cessation in substance use treatment patients.

Authors:  Roberto Secades-Villa; Gema Aonso-Diego; Alba González-Roz
Journal:  Int J Clin Health Psychol       Date:  2022-05-26

Review 4.  Practical Technology for Expanding and Improving Substance Use Disorder Treatment: Telehealth, Remote Monitoring, and Digital Health Interventions.

Authors:  Mary M Sweeney; August F Holtyn; Maxine L Stitzer; David R Gastfriend
Journal:  Psychiatr Clin North Am       Date:  2022-07-31

5.  A Smartphone-Smartcard Platform for Implementing Contingency Management in Buprenorphine Maintenance Patients With Concurrent Stimulant Use Disorder.

Authors:  Anthony DeFulio; Joshua Furgeson; Hayley D Brown; Shawn Ryan
Journal:  Front Psychiatry       Date:  2021-12-07       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.